CRISPR‐Enhanced RAA‐SHERLOCK Assay for Point‐of‐Care Detection of Cyprinid Herpesvirus‐3: Development, Validation and Clinical Application
Journal of Fish Diseases · 2025
DOI: 10.1111/jfd.70079 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Fish Diseases, 2025. Verfasst von Hatem Soliman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Division of Fish Health, University of Veterinary Medicine, Vienna, Austria. Hauptthemen laut MEDLINE: Fish Diseases, Herpesviridae, Herpesviridae Infections, Carps. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Veterinary Medicine University, Academy of Scientific Research and Technology.
Abstract (Originalsprache)
Koi herpesvirus disease (KHVD), caused by Cyprinid herpesvirus ‐3 (CyHV‐3), poses a significant threat to global aquaculture due to its high mortality rates and economic impact. Current diagnostic methods, such as PCR, are limited by equipment dependency and procedural complexity, hindering point‐of‐care (POC) applications. To address this, we developed an integrated assay combining recombinase‐aided amplification (RAA) with CRISPR‐Cas13a‐mediated SHERLOCK technology and lateral flow detection (LFD) for rapid and visual detection of CyHV‐3 in clinical samples. The KHV‐SHERLOCK assay targets a conserved region of the CyHV‐3 thymidine kinase (TK) gene, demonstrating exceptional specificity with no cross‐reactivity to related pathogens or host DNA. Sensitivity evaluations revealed a detection limit of 100 ag/μL for CyHV‐3 plasmid DNA, tenfold more sensitive than the conventional PCR (1 fg/μL) assay, even in the presence of 100 ng of carp genomic DNA as background interference. Clinical validation using 50 archived samples showed 100% concordance with reference PCR results, confirming diagnostic reliability. The assay's isothermal RAA step (37°C, 40 min) and CRISPR‐Cas13a detection (37°C, 1 h) enable equipment‐free operation, while LFD provides unambiguous visual results within minutes. This platform merges high sensitivity with POC practicality, offering a transformative tool for field‐based KHVD surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Division of Fish Health, University of Veterinary Medicine, Vienna, Austria.
- Academy of Scientific Research & Technology, Cairo, Egypt.
- Department of Aquatic Animal Medicine and Management, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt.
Förderung
- Veterinary Medicine University
- Academy of Scientific Research and Technology
Zitieren
APA
Soliman, H., Akram, N., & Saleh, M. (2025). CRISPR‐Enhanced RAA‐SHERLOCK Assay for Point‐of‐Care Detection of Cyprinid Herpesvirus‐3: Development, Validation and Clinical Application. Journal of Fish Diseases. https://doi.org/10.1111/jfd.70079
Vancouver
Soliman H, Akram N, Saleh M. CRISPR‐Enhanced RAA‐SHERLOCK Assay for Point‐of‐Care Detection of Cyprinid Herpesvirus‐3: Development, Validation and Clinical Application. Journal of Fish Diseases. 2025. doi:10.1111/jfd.70079
BibTeX
@article{Soliman2025,
author = {Soliman, Hatem and Akram, Naveed and Saleh, Mona},
title = {CRISPR‐Enhanced RAA‐SHERLOCK Assay for Point‐of‐Care Detection of Cyprinid Herpesvirus‐3: Development, Validation and Clinical Application},
journal = {Journal of Fish Diseases},
year = {2025},
doi = {10.1111/jfd.70079}
}
EUVIMED